| Primary |
| Product Used For Unknown Indication |
40.9% |
| Insomnia |
8.7% |
| Cardiac Disorder |
6.3% |
| Suicide Attempt |
5.5% |
| Drug Use For Unknown Indication |
4.7% |
| Vitamin Supplementation |
4.7% |
| Premedication |
3.9% |
| Intentional Drug Misuse |
3.1% |
| Cardiovascular Event Prophylaxis |
2.4% |
| Cough |
2.4% |
| Depression |
2.4% |
| Nasopharyngitis |
2.4% |
| Accidental Exposure |
1.6% |
| Analgesic Therapy |
1.6% |
| Arthropod Sting |
1.6% |
| Blood Pressure |
1.6% |
| Hypersensitivity |
1.6% |
| Hypertension |
1.6% |
| Ovarian Cancer Stage Iii |
1.6% |
| Pain |
1.6% |
|
| Toxicity To Various Agents |
43.8% |
| Completed Suicide |
8.6% |
| Drug Abuse |
7.0% |
| Intentional Overdose |
7.0% |
| Death |
3.1% |
| Intentional Drug Misuse |
3.1% |
| Overdose |
3.1% |
| Hypersensitivity |
2.3% |
| Ill-defined Disorder |
2.3% |
| Somnolence |
2.3% |
| Tachycardia |
2.3% |
| Vomiting |
2.3% |
| Cardio-respiratory Arrest |
1.6% |
| Hypoxic-ischaemic Encephalopathy |
1.6% |
| Medication Error |
1.6% |
| Respiratory Arrest |
1.6% |
| Status Epilepticus |
1.6% |
| Tremor |
1.6% |
| Underdose |
1.6% |
| Unresponsive To Stimuli |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
43.8% |
| Drug Use For Unknown Indication |
24.9% |
| Insomnia |
3.6% |
| Breast Cancer Recurrent |
2.7% |
| Depression |
2.5% |
| Breast Cancer |
2.3% |
| Premedication |
2.3% |
| Suicide Attempt |
2.1% |
| Foetal Exposure During Pregnancy |
1.5% |
| Food Allergy |
1.5% |
| Intentional Drug Misuse |
1.5% |
| Pain Management |
1.5% |
| Pruritus |
1.5% |
| Swollen Tongue |
1.5% |
| Drug Use For Unknown Indication |
1.3% |
| Hypertension |
1.1% |
| Pain |
1.1% |
| Prophylaxis |
1.1% |
| Chemotherapy |
1.0% |
| Completed Suicide |
1.0% |
|
| Toxicity To Various Agents |
14.9% |
| Overdose |
8.8% |
| Completed Suicide |
7.0% |
| Suicide Attempt |
7.0% |
| Mental Disorder |
6.1% |
| Tremor |
6.1% |
| Intentional Overdose |
5.3% |
| Drug Toxicity |
4.4% |
| Medication Error |
4.4% |
| Pain In Extremity |
4.4% |
| Respiratory Arrest |
4.4% |
| Unresponsive To Stimuli |
4.4% |
| Cardio-respiratory Arrest |
3.5% |
| Drug Ineffective |
3.5% |
| Rash |
3.5% |
| Off Label Use |
2.6% |
| Somnolence |
2.6% |
| Tachycardia |
2.6% |
| Urticaria |
2.6% |
| Convulsion |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.4% |
| Drug Use For Unknown Indication |
24.1% |
| Premedication |
9.9% |
| Prophylaxis |
6.5% |
| Rheumatoid Arthritis |
3.5% |
| Pain |
3.2% |
| Hypertension |
3.1% |
| Insomnia |
2.5% |
| Aplastic Anaemia |
2.1% |
| Nausea |
1.9% |
| Crohn's Disease |
1.7% |
| Acute Myeloid Leukaemia |
1.7% |
| Depression |
1.6% |
| Constipation |
1.5% |
| Rash |
1.4% |
| Mantle Cell Lymphoma |
1.3% |
| Anxiety |
1.3% |
| Infection Prophylaxis |
1.3% |
| Cancer Pain |
1.2% |
| Prophylaxis Of Nausea And Vomiting |
1.1% |
|
| Vomiting |
20.5% |
| White Blood Cell Count Decreased |
12.1% |
| Weight Decreased |
6.7% |
| Pyrexia |
5.7% |
| Urticaria |
5.7% |
| Urinary Tract Infection |
5.0% |
| Thrombocytopenia |
4.7% |
| Tachycardia |
3.7% |
| Death |
3.4% |
| Pruritus |
3.4% |
| Somnolence |
3.4% |
| Suicide Attempt |
3.4% |
| Pneumonia |
3.0% |
| Rash |
3.0% |
| Weight Increased |
3.0% |
| Acute Myeloid Leukaemia |
2.7% |
| Nausea |
2.7% |
| Pleural Effusion |
2.7% |
| Pulmonary Embolism |
2.7% |
| Respiratory Failure |
2.7% |
|
| Interacting |
| Ill-defined Disorder |
45.8% |
| Parkinson's Disease |
16.7% |
| Product Used For Unknown Indication |
8.3% |
| Sleep Disorder |
8.3% |
| Bronchitis |
4.2% |
| Cellulitis |
4.2% |
| Prophylaxis |
4.2% |
| Retinoblastoma |
4.2% |
| Thrombosis Prophylaxis |
4.2% |
|
| Hypersensitivity |
14.3% |
| Hypotonia |
14.3% |
| Multiple Drug Overdose |
14.3% |
| Muscular Weakness |
14.3% |
| Off Label Use |
14.3% |
| Rash |
14.3% |
| Toxicity To Various Agents |
14.3% |
|
